News

FDA approves Benlysta autoinjector for pediatric patients with active lupus nephritis
The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
Clinical Advisor4d
GINA 2025 Asthma Update: More on T2 Biomarkers, Young Children, Revised Charts
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...
BMJ6d
What causes prescribing errors in children? Scoping review
These typically identified errors using drug chart/medical record review (21 studies; 42%) or incident reporting (13 studies; 26%). In 20 of the 44 primary studies (45%), factors associated with ...